NCT05020496View on ClinicalTrials.gov

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

October 1, 2026

Conditions
Skin Diseases
Interventions
DRUG

Diphenylcyclopropenone (DPCP)

Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients

Trial Locations (1)

35294

Whitaker Clinic, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER